To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Novalis Biotech raises 8m euros for sophomore fund
Novalis Biotech, a healthcare-focused early-stage venture firm, has raised 8 million euros for its second fund.
